
Sign up to save your podcasts
Or
Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India
3.4
1111 ratings
Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India
7,829 Listeners
451 Listeners
538 Listeners
311 Listeners
450 Listeners
1,112 Listeners
14 Listeners
59 Listeners
89 Listeners
44 Listeners
2 Listeners
15 Listeners
81 Listeners
9 Listeners
17 Listeners